Does CARBOPLATIN Cause Hypopituitarism? 89 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 89 reports of Hypopituitarism have been filed in association with CARBOPLATIN (Carboplatin). This represents 0.1% of all adverse event reports for CARBOPLATIN.
89
Reports of Hypopituitarism with CARBOPLATIN
0.1%
of all CARBOPLATIN reports
6
Deaths
56
Hospitalizations
How Dangerous Is Hypopituitarism From CARBOPLATIN?
Of the 89 reports, 6 (6.7%) resulted in death, 56 (62.9%) required hospitalization, and 13 (14.6%) were considered life-threatening.
Is Hypopituitarism Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CARBOPLATIN. However, 89 reports have been filed with the FAERS database.
What Other Side Effects Does CARBOPLATIN Cause?
Off label use (6,100)
Neutropenia (5,314)
Anaemia (5,312)
Febrile neutropenia (4,888)
Nausea (4,588)
Disease progression (4,538)
Thrombocytopenia (4,483)
Malignant neoplasm progression (4,177)
Diarrhoea (4,154)
Dyspnoea (3,494)
What Other Drugs Cause Hypopituitarism?
NIVOLUMAB (455)
IPILIMUMAB (391)
PEMBROLIZUMAB (203)
ATEZOLIZUMAB (71)
SOMATROPIN (67)
PACLITAXEL (64)
BEVACIZUMAB (45)
PREDNISONE (41)
DURVALUMAB (38)
LENVATINIB (34)
Which CARBOPLATIN Alternatives Have Lower Hypopituitarism Risk?
CARBOPLATIN vs CARBOPROST TROMETHAMINE
CARBOPLATIN vs CARBOXYMETHYLCELLULOSE
CARBOPLATIN vs CARBOXYMETHYLCELLULOSE\GLYCERIN
CARBOPLATIN vs CARBOXYMETHYLCELLULOSE\GLYCERIN\POLYSORBATE 80
CARBOPLATIN vs CARBOXYMETHYLCELLULOSE\HYPROMELLOSES